• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.

作者信息

Sierra E E, Brigle K E, Spinella M J, Goldman I D

机构信息

Department of Medicine, Einstein Cancer Center, Bronx, NY 10461, USA.

出版信息

Biochem Pharmacol. 1997 Jan 24;53(2):223-31. doi: 10.1016/s0006-2952(96)00730-7.

DOI:10.1016/s0006-2952(96)00730-7
PMID:9037255
Abstract

F2-MTX'A is an L1210 leukemia cell line with a functional detect in the reduced folate carrier and high level expression of folate receptor beta. The pH dependence of methotrexate (MTX) influx by folate receptor beta in F2-MTX'A cells was characterized and compared with that of the reduced folate carrier in parental L1210 cells. MTX influx by folate receptor beta had a pH optimum of 6.5, whereas influx mediated by the reduced folate carrier showed a pH optimum of 7.5. Increased folate receptor beta-mediated MTX influx at pH 6.5 relative to pH 7.5 was accompanied by a 5-fold increase in binding affinity of the receptor for MTX without a change in the number of binding sites. At pH 6.2, approximately 24% of MTX influx in F2-MTX'A cells proceeded by another mechanism. This transport route became active at pH < 7.5, operated optimally at pH 6.0 to 6.5, and, unlike folate receptor beta-mediated MTX influx, was insensitive to the presence of low levels of folic acid (100 nM). MTX influx by the low pH system showed saturability, with a Ki of 5.3 microM and a Vmax of 1.53 nmol/g dry wt/min, was energy dependent, was inhibited by sulfobromophthalein with a Ki of 148 microM, and had similar relative affinities for folic acid, leucovorin, and 5 methyltetrahydrofolate. Influx of 5-methyltetrahydrofolate was also mediated by this route. The data provide further confirmatory evidence for an MTX influx route in F2-MTX'A cells, optimal at low pH and distinct from the reduced folate carrier or the folate receptor.

摘要

相似文献

1
pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
Biochem Pharmacol. 1997 Jan 24;53(2):223-31. doi: 10.1016/s0006-2952(96)00730-7.
2
Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.对具有缺陷的还原型叶酸载体功能的小鼠L1210白血病细胞中由低pH途径介导的叶酸转运的表征。
Biochem Pharmacol. 1998 May 1;55(9):1505-12. doi: 10.1016/s0006-2952(97)00673-4.
3
Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.小鼠L1210白血病细胞中还原型叶酸载体与叶酸受体转运特性的比较。
Biochem Pharmacol. 1995 Oct 12;50(8):1287-94. doi: 10.1016/0006-2952(95)94097-y.
4
Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.区分L1210白血病细胞中叶酸受体α介导的转运和还原型叶酸载体介导的转运。
J Biol Chem. 1995 Apr 7;270(14):7842-9. doi: 10.1074/jbc.270.14.7842.
5
Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects.当甲氨蝶呤的内流由还原型叶酸载体或叶酸受体介导时,L1210白血病细胞中甲氨蝶呤多聚谷氨酸化的比较。缺乏内流途径特异性效应的证据。
Biochem Pharmacol. 1996 Sep 13;52(5):703-12. doi: 10.1016/0006-2952(96)00347-4.
6
The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.多靶点抗叶酸剂(MTA)的转运机制及其在甲氨蝶呤转运明显受损的细胞中的交叉耐药模式。
Clin Cancer Res. 2000 Sep;6(9):3687-95.
7
Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.通过在还原型叶酸载体预测的第八个跨膜结构域中用苯丙氨酸替代丝氨酸,来区分还原型叶酸和甲氨蝶呤作为转运底物的差异。
Biochem Pharmacol. 1999 Nov 15;58(10):1615-24. doi: 10.1016/s0006-2952(99)00257-9.
8
A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.一种突变的小鼠还原型叶酸载体(RFC1),对叶酸的亲和力增加,对甲氨蝶呤的亲和力降低,且其转运功能需要必需阴离子。
J Biol Chem. 1998 Jul 24;273(30):19065-71. doi: 10.1074/jbc.273.30.19065.
9
Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.癌基因表达对费希尔大鼠3T3细胞中两种内化叶酸化合物的载体介导系统的不同影响。
J Cell Physiol. 2000 Sep;184(3):364-72. doi: 10.1002/1097-4652(200009)184:3<364::AID-JCP11>3.0.CO;2-N.
10
A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.一种还原型叶酸载体突变在鼠白血病细胞中产生载体迁移率的底物依赖性改变以及甲氨蝶呤耐药性,同时保持在5-甲酰四氢叶酸存在下的生长。
J Biol Chem. 1998 Apr 3;273(14):7873-9. doi: 10.1074/jbc.273.14.7873.

引用本文的文献

1
Impact of genetic variants in the solute carrier () genes encoding drug uptake transporters on the response to anticancer chemotherapy.编码药物摄取转运蛋白的溶质载体(SLC)基因中的遗传变异对抗癌化疗反应的影响。
Cancer Drug Resist. 2024 Jul 18;7:27. doi: 10.20517/cdr.2024.42. eCollection 2024.
2
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy.溶质载体转运体在高效抗癌药物递送与治疗中的作用
Pharmaceutics. 2023 Jan 21;15(2):364. doi: 10.3390/pharmaceutics15020364.
3
Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.
主要易化型叶酸转运蛋白SLC19A1和SLC46A1的生物学特性
Curr Top Membr. 2014;73:175-204. doi: 10.1016/B978-0-12-800223-0.00004-9.
4
The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.主要促进叶酸转运蛋白溶质载体 19A1 和溶质载体 46A1:生物学及在癌症抗叶酸化疗中的作用。
Drug Metab Dispos. 2014 Apr;42(4):632-49. doi: 10.1124/dmd.113.055723. Epub 2014 Jan 6.
5
Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.设计并体外验证多价树状物甲氨蝶呤作为叶酸靶向抗癌治疗药物。
Curr Pharm Des. 2013;19(37):6594-605. doi: 10.2174/1381612811319370004.
6
Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.膜转运蛋白与叶酸稳态:肠道吸收以及向全身各腔室和组织的转运
Expert Rev Mol Med. 2009 Jan 28;11:e4. doi: 10.1017/S1462399409000969.
7
The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation. RFC as a double edged sword in folate homeostasis.在严重叶酸缺乏的情况下,还原型叶酸载体(RFC)对细胞具有细胞毒性。RFC在叶酸稳态中是一把双刃剑。
J Biol Chem. 2008 Jul 25;283(30):20687-95. doi: 10.1074/jbc.M802812200. Epub 2008 May 22.
8
Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds.膳食化合物对培养的人结肠腺癌Caco-2细胞中叶酸摄取的调节作用。
Eur J Nutr. 2007 Sep;46(6):329-36. doi: 10.1007/s00394-007-0670-y. Epub 2007 Aug 21.